Medical Marijuana for Cancer in Florida
Medical cannabis helps manage cancer-related pain, nausea, and treatment side effects.
Medically reviewed by Bruce Stratt, MD
Board-Certified Physician · OMMU Certified · Boca Raton, FL
Overview
Cancer encompasses over 100 distinct diseases characterized by uncontrolled cell growth. Cancer and its treatments — including chemotherapy, radiation, and immunotherapy — frequently cause debilitating symptoms including severe pain, nausea, vomiting, loss of appetite, cachexia (muscle wasting), fatigue, and depression. These side effects can significantly compromise a patient's ability to tolerate curative therapies and maintain quality of life during what is already an extraordinarily difficult time.
Florida law explicitly recognizes cancer as a qualifying condition for medical marijuana certification under Statute 381.986. Cancer patients often find that conventional antiemetic and analgesic medications provide insufficient relief — particularly for chemotherapy-induced nausea and vomiting (CINV) that persists despite standard antiemetics like ondansetron. Many patients are seeking alternatives that offer better symptom management with fewer adverse effects, and medical cannabis has become an increasingly important component of supportive oncology care.
The scale of the need is significant: approximately 1.9 million Americans are diagnosed with cancer each year, and the majority will experience treatment-related symptoms severe enough to impact daily functioning. For patients in Florida, medical cannabis certification provides legal access to a range of products — from low-dose tinctures and capsules to vaporized flower — that can be tailored to specific symptom profiles and integrated alongside conventional oncology treatments.
How Medical Cannabis May Help
Medical cannabis is well-supported by clinical evidence for managing cancer-related symptoms. A Phase II randomized, double-blind trial (Grimison et al., Annals of Oncology, 2020) found that THC:CBD extract nearly doubled the complete response rate for refractory chemotherapy-induced nausea and vomiting — from 14% with placebo to 25% with cannabis — and 83% of participants preferred the cannabis treatment to placebo. THC activates CB1 receptors in the brainstem's vomiting center, suppressing the nausea reflex through the same mechanism targeted by ondansetron-class antiemetics. Both THC and CBD contribute to appetite stimulation, helping patients maintain weight and nutritional status during treatment — a critical factor in treatment outcomes and survival. The FDA has approved two synthetic cannabinoid medications — dronabinol (Marinol) and nabilone (Cesamet) — specifically for chemotherapy-related nausea, validating the therapeutic approach. Cannabis-based pain management provides an important adjunct or alternative to opioid analgesics, potentially reducing dependency risk. A landmark 2018 Israeli study of 2,970 cancer patients (Bar-Lev Schleider et al., European Journal of Internal Medicine) found that after six months of medical cannabis therapy, 36% of patients stopped taking opioids entirely, quality-of-life ratings improved from 18.7% reporting "good" to 69.5%, and 95.9% reported overall improvement in their condition. Many cancer patients also report that cannabis helps them sleep better, reduces treatment-related anxiety, and improves their overall sense of well-being. Dr. Stratt provides compassionate, individualized cannabis recommendations that work alongside your oncology treatment plan.
Individual results vary. Consult with Dr. Stratt to understand how cannabis therapy may apply to your specific situation.
What to Bring to Your Appointment
Bring your Florida ID and oncology records, chemotherapy or radiation treatment documentation, and any pain management prescriptions. Pathology reports or diagnosis letters are helpful.
Frequently Asked Questions
Related Articles
Patient Resources
Get Your Medical Marijuana Card for Cancer
Schedule your evaluation with Dr. Stratt. Same-day state registry submissions for qualifying patients.